Shares of Plus500 Ltd. (LON:PLUS – Get Free Report) reached a new 52-week high on Monday . The company traded as high as GBX 2,190 ($27.51) and last traded at GBX 2,152.76 ($27.04), with a volume of 84132 shares traded. The stock had previously closed at GBX 2,156 ($27.08).
Analyst Upgrades and Downgrades
A number of research analysts have weighed in on PLUS shares. Jefferies Financial Group reiterated a “buy” rating and set a GBX 2,300 ($28.89) target price on shares of Plus500 in a report on Tuesday, February 20th. Canaccord Genuity Group upped their price target on Plus500 from GBX 1,623 ($20.39) to GBX 1,883 ($23.65) and gave the stock a “speculative buy” rating in a research note on Friday, March 1st.
Read Our Latest Research Report on PLUS
Plus500 Price Performance
Plus500 Increases Dividend
The business also recently declared a dividend, which will be paid on Thursday, July 11th. Investors of record on Thursday, February 29th will be paid a $0.95 dividend. The ex-dividend date is Thursday, February 29th. This represents a dividend yield of 4.11%. This is an increase from Plus500’s previous dividend of $0.73. Plus500’s dividend payout ratio is presently 2,620.97%.
About Plus500
Plus500 Ltd., a fintech company, operates technology-based trading platforms in Europe, the United Kingdom, Australia, and internationally. The company develops and operates an online trading platform, including over the counter (OTC) products comprising the contracts for difference (CFDs) sector enabling its international customer base of individual customers to trade CFDs on underlying financial instruments comprising shares, indices, commodities, options, ETFs, foreign exchange, and cryptocurrencies internationally.
See Also
- Five stocks we like better than Plus500
- Election Stocks: How Elections Affect the Stock Market
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Are Penny Stocks a Good Fit for Your Portfolio?
- Hilton Demonstrates Asset Light is Right for Investors
- Retail Stocks Investing, Explained
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Plus500 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plus500 and related companies with MarketBeat.com's FREE daily email newsletter.